Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | MGAM | O43451 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | SI | P14410 | 1/20 | 0.44 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.44 |
| ▸ | GSK3A | P49840 | 1/20 | 0.44 |
| ▸ | GSK3B | P49841 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | ELANE | P08246 | 1/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11116362 | 0.98 | LMNA (0.46) | LMNAMGAMGAASIMGAM2 | |
| SCHEMBL29419289 | 0.96 | ALDH1A1 (0.45) | LMNAMGAMGAASIMGAM2 | |
| SCHEMBL65358 | 0.94 | ALDH1A1 (0.46) | LMNAMGAMGAASIMGAM2 | |
| SCHEMBL11852921 | 0.94 | — | — | |
| SCHEMBL2373233 | 0.94 | MGAM (0.50) | LMNAMGAMGAASIMGAM2 | |
| SCHEMBL3966571 | 0.94 | MGAM (0.50) | LMNAMGAMGAASIMGAM2 | |
| SCHEMBL8912811 | 0.94 | MGAM (0.50) | LMNAMGAMGAASIMGAM2 | |
| SCHEMBL20853804 | 0.93 | LMNA (0.41) | LMNAMGAMGAASIMGAM2 | |
| SCHEMBL16838292 | 0.93 | LMNA (0.41) | LMNAMGAMGAASIMGAM2 | |
| Bromide SCHEMBL18396974 | 0.92 | ALDH1A1 (0.45) | LMNAMGAMGAASIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230182088-A1 | METHOD FOR PREPARING HIGH-SELECTIVITY LITHIUM-MAGNESIUM SEPARATION MEMBRANE | TIANJIN UNIVERSITY (CN) | 2023-06-15 | — | — | US | claimed |
| WO-2025121238-A1 | METHOD FOR PRODUCING AROMATIC POLYSULFONE | 住友化学株式会社 | 2025-06-12 | — | — | WO | disclosed |
| CN-113453720-B | Dual ligand drug conjugate and uses thereof | 同宜医药（苏州）有限公司 | 2025-05-06 | — | — | CN | disclosed |
| US-20240283004-A1 | POWER STORAGE DEVICE | Prime Planet Energy & Solutions, Inc. (JP) | 2024-08-22 | — | — | US | disclosed |
| EP-4415102-A1 | POWER STORAGE DEVICE | Prime Planet Energy & Solutions, Inc. (JP) | 2024-08-14 | — | — | EP | disclosed |
| CN-118472380-A | Power storage device | 泰星能源解决方案有限公司 | 2024-08-09 | — | — | CN | disclosed |
| US-20230182088-A1 | METHOD FOR PREPARING HIGH-SELECTIVITY LITHIUM-MAGNESIUM SEPARATION MEMBRANE | TIANJIN UNIVERSITY (CN) | 2023-06-15 | — | — | US | disclosed |
| CN-115633511-A | Perovskite solar cell and preparation method thereof | 宣城先进光伏技术有限公司 | 2023-01-20 | — | — | CN | disclosed |
| US-20220175761-A1 | BI-LIGAND DRUG CONJUGATE AND USE THEREOF | COHERENT BIOPHARMA SUZHOU LTD (CN) | 2022-06-09 | — | — | US | disclosed |
| US-11274268-B2 | Detergent compositions for removing heavy metals and formaldehyde | FNG RESEARCH CO., LTD. (KR) | 2022-03-15 | — | — | US | disclosed |
| EP-3544953-A1 | COMPOSITIONS FOR PROTECTING THE SKIN FROM HEAVY METALS AND FORMALDEHYDE | FNG Research Co., Ltd. (KR) | 2019-10-02 | — | — | EP | disclosed |
| EP-3538631-A1 | DETERGENT COMPOSITIONS FOR REMOVING HEAVY METALS AND FORMALDEHYDE | FNG Research Co., Ltd. (KR) | 2019-09-18 | — | — | EP | disclosed |
| WO-2018174337-A1 | DETERGENT COMPOSITIONS FOR REMOVING HEAVY METALS AND FORMALDEHYDE | FNG RESEARCH CO., LTD. (KR) | 2018-09-27 | — | — | WO | disclosed |
| WO-2018097431-A1 | COMPOSITIONS FOR PROTECTING THE SKIN FROM HEAVY METALS AND FORMALDEHYDE | FNG RESEARCH CO., LTD. (KR) | 2018-05-31 | — | — | WO | disclosed |
| US-8841384-B2 | Material comprising polyazacycloalkanes, grafted on polypropylene fibres, its process of preparation, and process for removing metal cations from a liquid | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2014-09-23 | — | — | US | disclosed |
| US-8841384-B2 | Material comprising polyazacycloalkanes, grafted on polypropylene fibres, its process of preparation, and process for removing metal cations from a liquid | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2014-09-23 | — | — | US | disclosed |
| US-8841384-B2 | Material comprising polyazacycloalkanes, grafted on polypropylene fibres, its process of preparation, and process for removing metal cations from a liquid | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2014-09-23 | — | — | US | disclosed |
| EP-2109632-B1 | MATERIAL COMPRISING POLYAZACYCLOALKANES GRAFTED ONTO POLYPROPYLENE FIBRES METHOD FOR PRODUCTION THEREOF AND METHOD FOR REMOVAL OF METAL CATIONS FROM A LIQUID | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2012-02-29 | — | — | EP | disclosed |
| US-20100059446-A1 | MATERIAL COMPRISING POLYAZACYCLOALKANES, GRAFTED ON POLYPROPYLENE FIBRES, ITS PROCESS OF PREPARATION, AND PROCESS FOR REMOVING METAL CATIONS FROM A LIQUID | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2010-03-11 | — | — | US | disclosed |
| US-20100059446-A1 | MATERIAL COMPRISING POLYAZACYCLOALKANES, GRAFTED ON POLYPROPYLENE FIBRES, ITS PROCESS OF PREPARATION, AND PROCESS FOR REMOVING METAL CATIONS FROM A LIQUID | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2010-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220175761-A1 | BI-LIGAND DRUG CONJUGATE AND USE THEREOF | SLC10A1, CD47, SELPLG | LMNA 4163/4885MGAM 3228/4885GAA 319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.